A new tool could aid in giving high-risk infants the RSV vaccination priority.

Published Date: 22 May 2024

Following the lack of nirsevimab for the prevention of infant respiratory syncytial virus (RSV) lower respiratory tract infections (LRTIs), a new tool may be able to identify newborns who are most at risk of developing serious RSV LRTIs.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot